Literature DB >> 15893711

Clinical and pathological characteristics of Mikulicz's disease (IgG4-related plasmacytic exocrinopathy).

Motohisa Yamamoto1, Hiroki Takahashi, Susumu Sugai, Kohzoh Imai.   

Abstract

Mikulicz's disease (MD) has been considered part of primary Sjogren's syndrome (SS) since Morgan's report in 1953. MD represents a unique condition involving enlargement of the lacrimal and salivary glands, as is also seen in SS; however, MD is characterized by few autoimmune reaction and its good responsiveness to glucocorticoid. Recent reports have shown that the frequency of apoptosis in glands of MD patients is lower when compared with SS. This phenomenon reflects the histologically reversible gland secretion in MD. Elevated IgG4 concentrations in the serum and prominent infiltration by plasmacytes expressing IgG4 in the lacrimal and salivary glands have also been confirmed in MD. Plasma cells expressing IgG4 are also detected in lymph nodes and bone marrow. MD may be a systemic disease, rather than a lacrimal and salivary gland disease. We here propose the new entity "IgG4-related plasmacytic exocrinopathy" and expect future development with regard to its relationship with autoimmune pancreatitis, which similarly presents elevated serum IgG4 levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15893711     DOI: 10.1016/j.autrev.2004.10.005

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  53 in total

Review 1.  Non-infectious environmental antigens as a trigger for the initiation of an autoimmune skin disease.

Authors:  Ye Qian; Donna A Culton; Joseph S Jeong; Nicole Trupiano; Jesus G Valenzuela; Luis A Diaz
Journal:  Autoimmun Rev       Date:  2016-07-08       Impact factor: 9.754

Review 2.  Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis.

Authors:  Kazuichi Okazaki; Kazushige Uchida; Toshiro Fukui
Journal:  J Gastroenterol       Date:  2008-07-04       Impact factor: 7.527

3.  A case of Mikulicz's disease complicated with severe interstitial nephritis associated with IgG4.

Authors:  Asuka Aoki; Keitaro Sato; Mitsuyo Itabashi; Takashi Takei; Takumi Yoshida; Junko Arai; Keiko Uchida; Ken Tsuchiya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2009-01-14       Impact factor: 2.801

4.  Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.

Authors:  Takashi Maehara; Hamid Mattoo; Miho Ohta; Vinay S Mahajan; Masafumi Moriyama; Masaki Yamauchi; Jefte Drijvers; Seiji Nakamura; John H Stone; Shiv S Pillai
Journal:  Ann Rheum Dis       Date:  2016-06-29       Impact factor: 19.103

5.  Recent advances in autoimmune pancreatitis.

Authors:  Kazuichi Okazaki; Kazushige Uchida; Toshiro Fukui; Mitsunobu Matsushita; Makoto Takaoka
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-06

6.  A case of extraocular muscle swelling due to IgG4-related sclerosing disease.

Authors:  Tomoaki Higashiyama; Yasuhiro Nishida; Satoshi Ugi; Mitsuaki Ishida; Yoshihiko Nishio; Masahito Ohji
Journal:  Jpn J Ophthalmol       Date:  2011-05-13       Impact factor: 2.447

7.  IgG4-Related Disease Presenting as a Solitary Neck Mass.

Authors:  Tyler McKinnon; William T Randazzo; Brian D Kim; Paul Biddinger; Scott Forseen
Journal:  J Radiol Case Rep       Date:  2015-02-28

Review 8.  IgG4-related disease: a new kid on the block or an old aquaintance?

Authors:  Georg Beyer; Theresa Schwaiger; Markus M Lerch; Julia Mayerle
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

Review 9.  Lessons from diseases mimicking Sjögren's syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Josep Font
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 10.  A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease.

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Mikiko Ohara; Chisako Suzuki; Yasuyoshi Naishiro; Hiroyuki Yamamoto; Yasuhisa Shinomura; Kohzoh Imai
Journal:  Mod Rheumatol       Date:  2006-12-20       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.